Cart
sales@molnova.com
SC-52012
CAS No. 145643-15-8
SC-52012( —— )
Catalog No. M33119 CAS No. 145643-15-8
SC-52012 is a novel and potent fibrinogen receptor antagonist, an RGD mimetic, which inhibits platelet aggregation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 1064 | Get Quote |
|
| 5MG | 1710 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSC-52012
-
NoteResearch use only, not for human use.
-
Brief DescriptionSC-52012 is a novel and potent fibrinogen receptor antagonist, an RGD mimetic, which inhibits platelet aggregation.
-
DescriptionHY-19163 is an orally active fibrinogen receptor antagonist, with antiplatelet activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number145643-15-8
-
Formula Weight482.53
-
Molecular FormulaC25H30N4O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](C(N[C@@H](CC1=CC=CC=C1)C(O)=O)=O)(NC(CCCCC2=CC=C(C(=N)N)C=C2)=O)CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zablocki JA, et al. A novel series of orally active antiplatelet agents. Bioorg Med Chem. 1995 May;3(5):539-51.?
molnova catalog
related products
-
β-Aminoarteether
β-Aminoarteether (SM934 free base), an orally active derivative of Artemisinin, serves a pivotal role in the research of inflammation and autoimmune disorders, including those related to lupus diseases.
-
PAR-2(1-6) (human)
PAR-2 (1-6) (human) (SLIGKV), a peptide ligand, is a PAR-2 agonist.
-
Ac2-26 TFA (151988-3...
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
